Cancer Treatment CTHZ Stock
Cancer Treatment Price Chart
Cancer Treatment CTHZ Financial and Trading Overview
| Cancer Treatment stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0001 USD |
| Volume | 2.58K USD |
| Avg. Volume | 2.58K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.210948 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CTHZ Valuation Measures
| Enterprise Value | 401.27K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 9.326 |
| Enterprise Value/EBITDA | -0.657 |
Trading Information
Cancer Treatment Stock Price History
| Beta (5Y Monthly) | 1.210948 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
CTHZ Share Statistics
| Avg. Volume (3 month) | 2.58K USD |
| Avg. Daily Volume (10-Days) | 2.58K USD |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2002 |
| Most Recent Quarter (mrq) | February 28, 2003 |
| Next Fiscal Year End | May 31, 2003 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1463.25% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.65% |
| Return on Equity (ttm) | -119.77% |
Income Statement
| Revenue (ttm) | 43.03K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 58.78K USD |
| EBITDA | -610882 USD |
| Net Income Avi to Common (ttm) | -1044286 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 398.3K USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 504.29K USD |
| Total Debt/Equity (mrq) | 144.19 USD |
| Current Ratio (mrq) | 1.052 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -828279 USD |
| Levered Free Cash Flow (ttm) | -5329 USD |
Profile of Cancer Treatment
| Country | United States |
| State | NV |
| City | Carson City |
| Address | 202 North Curry Street |
| ZIP | 89703 |
| Phone | 212-221-1340 |
| Website | N/A |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company is based in Carson City, Nevada.
Q&A For Cancer Treatment Stock
What is a current CTHZ stock price?
Cancer Treatment CTHZ stock price today per share is 0.0001 USD.
How to purchase Cancer Treatment stock?
You can buy CTHZ shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cancer Treatment?
The stock symbol or ticker of Cancer Treatment is CTHZ.
How many shares does Cancer Treatment have in circulation?
The max supply of Cancer Treatment shares is 0.
What is Cancer Treatment Price to Earnings Ratio (PE Ratio)?
Cancer Treatment PE Ratio is 0.00000000 now.
What was Cancer Treatment earnings per share over the trailing 12 months (TTM)?
Cancer Treatment EPS is 0 USD over the trailing 12 months.